Gaceta sanitaria最新文献

Rejections and retractions for ethical concerns in Gaceta Sanitaria, 2024.

Gaceta sanitaria Pub Date : 2025-01-25 DOI: 10.1016/j.gaceta.2024.102446

Cristina Candal-Pedreira, Alberto Lana, Ferrán Catalá-López, Salvador Peiró

引用次数: 0

The influence of COVID-19 on the practice of physical activity in the European Union countries. 2019冠状病毒病对欧盟国家身体活动的影响。

Gaceta sanitaria Pub Date : 2025-01-16 DOI: 10.1016/j.gaceta.2024.102436

Diego Álvarez-Lourido, José Luis Paniza-Prados, Antonio Álvarez-Sousa

{"title":"The influence of COVID-19 on the practice of physical activity in the European Union countries.","authors":"Diego Álvarez-Lourido, José Luis Paniza-Prados, Antonio Álvarez-Sousa","doi":"10.1016/j.gaceta.2024.102436","DOIUrl":"https://doi.org/10.1016/j.gaceta.2024.102436","url":null,"abstract":"Objective: Analyze how pandemics contribute to the increase in social inequalities in the health sector.Method: Data are taken from Eurobarometer 97.3. We use the Generalized Structural Equation Model (GSEM) methodology for this analysis.Results: People with lower socio-economic status, considered to be of lower social class, living in areas with worse infrastructure for practicing physical activity, and in countries with high levels of social inequality, are less likely to engage in leisure time physical activity. In addition, these individuals are more likely to interrupt physical activity practices as a result of COVID-19. In contrast, people of higher socio-economic status, considered to be of upper class, living in contexts where there are opportunities for physical activity, and in countries with low levels of social inequality, are more likely/ to belong to the group of those who increased the frequency of practicing physical activity in free time/ to have increased the frequency of their leisure time physical activity.Conclusions: There are widespread inequalities in leisure time physical activity linked to personal variables (social status and subjective social class) and contextual variables (infrastructures and Gini Index) that were significantly aggravated with the COVID-19 pandemic.","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":"39 ","pages":"102436"},"PeriodicalIF":0.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

John Leonard McKnight, November 22,1931-November 2, 2024. 约翰·伦纳德·麦克奈特，1931年11月22日- 2024年11月2日。

Gaceta sanitaria Pub Date : 2025-01-16 DOI: 10.1016/j.gaceta.2024.102441

John R Ashton, Maggi Morris

引用次数: 0

Accompaniment of isolated people by volunteers from the neighborhood (ACOMPANYEM). A community trial with a nested qualitative study. 由社区志愿者（ACOMPANYEM）陪伴被隔离的人。一个嵌套定性研究的社区试验。

Gaceta sanitaria Pub Date : 2025-01-15 DOI: 10.1016/j.gaceta.2024.102442

Paloma Camós-Guijosa, Alba Caro-Durán, Eva Bellés-Mur, Benilde Domingo-Arasa, Yolanda Vasco-Rodríguez

{"title":"Accompaniment of isolated people by volunteers from the neighborhood (ACOMPANYEM). A community trial with a nested qualitative study.","authors":"Paloma Camós-Guijosa, Alba Caro-Durán, Eva Bellés-Mur, Benilde Domingo-Arasa, Yolanda Vasco-Rodríguez","doi":"10.1016/j.gaceta.2024.102442","DOIUrl":"https://doi.org/10.1016/j.gaceta.2024.102442","url":null,"abstract":"Introduction: Social prescription targets people with social isolation or unwanted loneliness and offers them community activities to improve their emotional well-being. Disabled homebound people cannot access social-health community assets. Neighborhood volunteers may accompany them at home or walk them outdoors. Community emotional well-being referent may enhance these interactions, conducting emotional counseling and management groups for volunteers.Objective: To evaluate the effectiveness of community intervention of accompaniment and emotional management with volunteers on unwanted loneliness in people with social isolation, their emotional well-being, and quality of life.Method: A community non-randomized trial on isolation with a qualitative nested study on unwanted loneliness. Detection by a driving group, made up of neighborhood organizations and the community health team, in an opportunistic way. Implementation of the multi-level volunteer-isolated people intervention. In cases where we detect architectural barriers, we will provide technical aids (portable stairlifts).","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":"39 ","pages":"102442"},"PeriodicalIF":0.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reform of economic evaluation of medicines in Spain: proposals from the Advisory Committee for Pharmaceutical Financing. 西班牙药品经济评价改革：药品筹资咨询委员会的建议。

Gaceta sanitaria Pub Date : 2025-01-15 DOI: 10.1016/j.gaceta.2024.102439

Marta Trapero-Bertran, Jaume Puig-Junoy, Emilio J Alegre-Del-Rey, Ana Clopés, Félix Lobo, Ana Ortega

{"title":"Reform of economic evaluation of medicines in Spain: proposals from the Advisory Committee for Pharmaceutical Financing.","authors":"Marta Trapero-Bertran, Jaume Puig-Junoy, Emilio J Alegre-Del-Rey, Ana Clopés, Félix Lobo, Ana Ortega","doi":"10.1016/j.gaceta.2024.102439","DOIUrl":"https://doi.org/10.1016/j.gaceta.2024.102439","url":null,"abstract":"This paper describes the reforms recommended by the Advisory Committee on the Financing of Pharmaceuticals (CAPF) for the National Health System (NHS) of Spain from 2019 to 2024 for the drug pricing and reimbursement process, to integrate economic evaluations and improve efficiency and sustainability. The CAPF has proposed a three-phase reform of the economic evaluation (EE) and budget impact analysis (BIA) processes. The first phase involves the mandatory submission of EE and BIA by applicants for new drugs. The second phase involves the assessment of these submissions, coordinated by the Directorate-General for Pharmaceuticals. The third phase focuses on the application of these assessments to decision-making on drug positioning, pricing and financing. The CAPF's recommendations emphasise improved regulation, transparency and the development of methodological guidelines for economic evaluations. These proposals include a dynamic appraisal system and the creation of official NHS guidance on EE and BIA. The process is designed to ensure compliance with established criteria and to incorporate efficiency into decision-making. The initiatives of the CAPF aim to make progress towards the integration of efficiency in Spanish pharmaceutical policy seeking to improve the methodological quality and transparency of economic evaluations, ultimately contributing to more informed decision-making and sustainable healthcare practices.","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":"39 ","pages":"102439"},"PeriodicalIF":0.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study. 胰高血糖素样肽-1受体激动剂与糖尿病和肥胖患者急性胰腺炎和胆道疾病的关联：一项倾向加权、基于人群的队列研究

Gaceta sanitaria Pub Date : 2025-01-15 DOI: 10.1016/j.gaceta.2024.102444

Celia Robles Cabanillas, Isabel Hurtado Navarro, Aníbal García-Sempere, Fran Llopis-Cardona, Francisco Sánchez-Sáez, Clara Rodríguez-Bernal, Gabriel Sanfélix-Gimeno

{"title":"Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.","authors":"Celia Robles Cabanillas, Isabel Hurtado Navarro, Aníbal García-Sempere, Fran Llopis-Cardona, Francisco Sánchez-Sáez, Clara Rodríguez-Bernal, Gabriel Sanfélix-Gimeno","doi":"10.1016/j.gaceta.2024.102444","DOIUrl":"https://doi.org/10.1016/j.gaceta.2024.102444","url":null,"abstract":"Objective: To evaluate the risk of acute pancreatitis and biliary disease in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA).Method: Population-based, propensity-weighted, new user, active comparator design study including patients with diabetes and obesity initiating treatment with GLP-1 RA or the comparator group sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in the region of Valencia from 2015 to 2021.Results: In adjusted, per protocol main analysis, no risk differences were found for acute pancreatitis (HR: 0.56; 95%CI: 0.17-1.91) nor for biliary disease (HR: 1.12; IC95%: 0.79, 1.58). Secondary analyses yielded similar results.Conclusions: Despite we did not observe increased risk of gastrointestinal events in GLP-1 RA vs SGLT-2i patients, adherence to approved indications and close monitoring of potential adverse events are warranted to ensure patient safety.","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":"39 ","pages":"102444"},"PeriodicalIF":0.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Radon mitigation in the workplace in Spain: a cross-sectional interview-based study. 西班牙工作场所的氡缓解：一项基于横断面访谈的研究。

Gaceta sanitaria Pub Date : 2025-01-15 DOI: 10.1016/j.gaceta.2024.102440

Lucía Martín-Gisbert, Alberto Ruano Raviña, Marta García-Talavera, Cristina Candal-Pedreira, Guadalupe García, Leonor Varela Lema, Mónica Pérez Ríos, Julia Rey-Brandariz

{"title":"Radon mitigation in the workplace in Spain: a cross-sectional interview-based study.","authors":"Lucía Martín-Gisbert, Alberto Ruano Raviña, Marta García-Talavera, Cristina Candal-Pedreira, Guadalupe García, Leonor Varela Lema, Mónica Pérez Ríos, Julia Rey-Brandariz","doi":"10.1016/j.gaceta.2024.102440","DOIUrl":"https://doi.org/10.1016/j.gaceta.2024.102440","url":null,"abstract":"Objective: To evaluate radon mitigation frequency and possible determinants for mitigation among employers in Spain, before the new regulation came into force. We also aimed to assess the reasons for not mitigating radon.Method: In this cross-sectional study, participants were systematically identified from all employers in Spain who had previously measured occupational radon through the Galician Radon Laboratory from 2015 until 2022. Employers responsible for at least one workplace where radon levels exceeded 300 Bq/m3 were included. Participants were interviewed via phone call by a trained interviewer. The information was recorded using an ad hoc questionnaire created as a result of a review. We analyzed mitigation frequency according to working sector, company size and maximum radon levels found. Reasons for not mitigating were ranked according to frequency.Results: We interviewed 32 employers (response rate 91%). Overall mitigation frequency was 53%. Mitigation frequency increased with the company size. For workplaces ≥1000 Bq/m3 mitigation frequency was 67%. Lack of perception of radon as a health risk was the main reason for not mitigating.Conclusions: Enhancing radon mitigation frequency in the workplace is a major area of improvement. We are of the opinion that employers need guidance and availability of mitigation services to comply with the new regulatory requirements in Spain.","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":"39 ","pages":"102440"},"PeriodicalIF":0.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[First records of two anthropophilic mosquito species in Segovia: implications for pathogen transmission]. [塞哥维亚两种嗜人类蚊子的首次记录：对病原体传播的影响]。

Gaceta sanitaria Pub Date : 2025-01-11 DOI: 10.1016/j.gaceta.2024.102438

Josué Martínez-de la Puente, Mikel A González

引用次数: 0

[Analysis of equity and budgetary sustainability of the pharmaceutical co-payment system in Spain]. [西班牙药品共同支付制度的公平性和预算可持续性分析]。

Gaceta sanitaria Pub Date : 2024-11-25 DOI: 10.1016/j.gaceta.2024.102427

Jaime Pinilla, Christian González-Martel, Beatriz González López-Valcárcel, Félix Lobo, Jaume Puig-Junoy

{"title":"[Analysis of equity and budgetary sustainability of the pharmaceutical co-payment system in Spain].","authors":"Jaime Pinilla, Christian González-Martel, Beatriz González López-Valcárcel, Félix Lobo, Jaume Puig-Junoy","doi":"10.1016/j.gaceta.2024.102427","DOIUrl":"https://doi.org/10.1016/j.gaceta.2024.102427","url":null,"abstract":"Objective: To estimate the impact of a more equitable pharmaceutical co-payment system by eliminating the distinction between active workers and pensioners, using only personal income as an adjustment parameter, defining more detailed income brackets, and introducing protective limits on personal expenditure.Method: Data from a random sample of 4,505,483 individuals residing in Spain were used, matching pharmaceutical consumption information from the Ministry of Health with economic data from the Tax Agency. Five microsimulation scenarios were designed, modifying co-payment percentages and monthly limits, and the effects on public pharmaceutical spending, the economic burden between patients and the Spanish National Health System, and the redistribution of the burden among patient groups were evaluated. The Kakwani index was used to measure the progressivity of each scenario.Results: The results show that equalizing active workers and pensioners and introducing more detailed income brackets can increase the progressivity of the co-payment system. In scenarios 2, 3, 4, and 5, the Kakwani index was higher than 0.2, indicating greater vertical equity. Public budgetary costs ranged from 48 million euros to 710.2 million euros. In all scenarios, the user's share of pharmaceutical expenditure decreased, especially for lower-income groups.Conclusions: A more progressive and equitable pharmaceutical co-payment system is feasible and can better protect low-income individuals without disproportionate budgetary impact. Eliminating the distinction between active workers and pensioners and exempting co-payments for incomes below 6,000 euros can significantly increase the system's equity.","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":" ","pages":"102427"},"PeriodicalIF":0.0,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142735415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Professional burnout: time for health policy]. [职业倦怠：是时候制定卫生政策了]。

Gaceta sanitaria Pub Date : 2024-04-01 DOI: 10.1016/j.gaceta.2024.102389

Vicente Ortún

引用次数: 0